Reaction
Intestinal Anastomosis reporting signals
As of the last recalculation, Intestinal Anastomosis appears in 620 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is CHOLESTYRAMINE (PRR 42.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cholestyramine | 15 | 42.7 | 42.7 |
| Vedolizumab | 92 | 41.9 | 42.0 |
| Adalimumab-Fkjp | 50 | 39.3 | 39.4 |
| Adalimumab-Aaty | 50 | 38.5 | 38.5 |
| Upadacitinib | 81 | 38.2 | 38.3 |
| Risankizumab-Rzaa | 78 | 36.5 | 36.5 |
| Adalimumab-Adaz | 50 | 34.5 | 34.5 |
| Mercaptopurine | 16 | 31.8 | 31.8 |
| Ustekinumab | 83 | 31.3 | 31.3 |
| Infliximab-Dyyb | 24 | 28.6 | 28.7 |
| Infliximab | 140 | 27.5 | 27.5 |
| Teduglutide | 10 | 25.3 | 25.3 |
| Mesalamine | 34 | 21.4 | 21.5 |
| Tofacitinib Citrate | 6 | 15.5 | 15.5 |